e Chlamydia pneumoniae is a Gram-negative bacterium that causes acute or chronic respiratory infections. As obligate intracellular pathogens, chlamydiae efficiently manipulate host cell processes to ensure their intracellular development. Here we focused on the interaction of chlamydiae with the host cell transcription factor activator protein 1 (AP-1) and its consequence on chlamydial development. During Chlamydia pneumoniae infection, the expression and activity of AP-1 family proteins c-Jun, c-Fos, and ATF-2 were regulated in a time-and dose-dependent manner. We observed that the c-Jun protein and its phosphorylation level significantly increased during C. pneumoniae development. Small interfering RNA knockdown of the c-Jun protein in HEp-2 cells reduced the chlamydial load, resulting in smaller inclusions and significantly lower chlamydial recovery. Furthermore, inhibition of the c-Jun-containing AP-1 complexes using tanshinone IIA changed the replicative infection phenotype into a persistent one. Tanshinone IIA-dependent persistence was characterized by smaller, aberrant inclusions, a strong decrease in the chlamydial load, and significantly reduced chlamydial recovery, as well as by the reversibility of the reduced recovery after the removal of tanshinone IIA. Interestingly, not only was tanshinone IIA treatment accompanied by a significant decrease of ATP levels, but fluorescence live cell imaging analysis by two-photon microscopy revealed that tanshinone IIA treatment also resulted in a decreased fluorescence lifetime of protein-bound NAD(P)H inside the chlamydial inclusion, indicating that chlamydial reticulate bodies have decreased metabolic activity. In all, these data demonstrate that the AP-1 transcription factor is involved in C. pneumoniae development, with tanshinone IIA treatment resulting in persistence.
Chlamydia pneumoniae is an obligate intracellular bacterium that causes acute and chronic infections of the upper and lower respiratory tract. The rate of seropositivity in most adult populations ranges from 60 to 90%, indicating the high worldwide prevalence of C. pneumoniae (1). During infection, chlamydiae exhibit a biphasic replication cycle with two distinct developmental forms, the infectious form, called the elementary body (EB), and the reticulate body (RB), which is the metabolically active and dividing form. Differentiation of EBs into RBs followed by replication occurs in a specialized vesicular compartment known as the inclusion (2). After replication the RBs start to redifferentiate into infectious EBs, which leave the cell, resulting in disease dissemination. In contrast, chlamydiae can also enter a persistent state, resulting in reduced infectivity and metabolic activity (3, 4). Some chlamydial proteins have been suggested to be indicators of chlamydial persistence, such as the major outer membrane protein (MOMP) and chlamydial heat shock protein 60 (cHsp60) (5, 6). Furthermore, persistence is characterized by an incomplete developmental cycle in line with the formation of a smal...